Advent Pharma Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 159.412 million compared to BDT 94.573 million a year ago. Operating income was BDT 62.072 million compared to BDT 29.750 million a year ago. Net income was BDT 44.902 million compared to BDT 17.546 million a year ago. Basic earnings per share was BDT 0.6 compared to BDT 0.29 a year ago. For the nine months, sales was BDT 489.320 million compared to BDT 279.454 million a year ago. Operating income was BDT 189.022 million compared to BDT 83.251 million a year ago. Net income was BDT 133.995 million compared to BDT 49.199 million a year ago. Basic earnings per share was BDT 1.78 compared to BDT 0.87 a year ago.